EFSA’s Use of Observational Data for Food Supplement Health Claims SSTSI 20.1.26 Health claims on food supplements carry significant scientific and regulatory responsibility. In the European Union, such claims must be supported by robust evidence demonstrating a clear relationship between the ingred...
MHRA Observational Evidence in Post-Brexit Herbal Approvals SSTSI 20.1.26 The regulatory landscape for herbal products in the United Kingdom has undergone a significant transformation following Brexit. With the UK no longer operating under the European Medicines Agency framework, the responsibility ...
Mapping Herbal Trials on WHO-ICTRP and ClinicalTrials.gov SSTSI 20.1.26 Herbal medicine is steadily moving from traditional knowledge systems into evidence-based global healthcare. As botanical products, plant-derived compounds, and multi-herb formulations enter formal clinical evaluation, the abili...
Building Hypotheses from Traditional Claims and Literature Data SSTSI 19.1.26 Traditional knowledge systems and modern scientific literature represent two of the richest sources of insight in research. Yet, they often exist in parallel worlds one rooted in centuries of experiential observation, the ...
African Regulatory Agencies and the Acceptance of Observational Studies in Traditional Use Registration SSTSI 17.1.26 As traditional medicines and herbal products gain wider recognition across global healthcare systems, regulatory frameworks are evolving to balance public health protection with resp...